Cosmo Pharmaceuticals NV (C43) Stock Price & News

C43:FRA

Cosmo Pharmaceuticals NV

€66.20

+1.69%

(+1.10) 1D

Jul 31, 10:00:00 PM GMT+2 · EUR

All symbols

YTD

MAX

	Symbol	Price	Change	% Change

Generating top insights for C43...

Open

€66.20

High

€66.30

Low

€66.20

Mkt. cap

1.06B

Avg. vol.

49.00

Volume

0.00

52-wk high

€141.00

52-wk low

€57.50

No. of employees

365

Open

€66.20

High

€66.30

Low

€66.20

Mkt. cap

1.06B

Avg. vol.

49.00

Volume

0.00

52-wk high

€141.00

52-wk low

€57.50

No. of employees

365

Related stocks

C53

China Reinsurance (Group) Corp

€0.14

-1.12%

C33

Chuan Hup Holdings Ltd

China Resources Bldg Mtrls Tech Hldg Ltd

€0.11

0.00%

News stories

From sources across the web

BigGo Finance

1 hour ago

CME Challenges Nasdaq Bitcoin Options Approval, Claims CFTC Has Exclusive Jurisdiction

FXLeaders

1 hour ago

Dow Jones Futures Rise as Oil Slides on Trump’s Iran Deal Comments

CNBC

11 hours ago

Nasdaq-100 just had worst month since March 2025. These stocks held up

Bloomberg.com

1 day ago

Warsh’s Silent Treatment Has S&P Traders Bracing for Wild Swings

About Cosmo Pharmaceuticals NV

CEO-

Employees365

Founded1997

Headquarters-

SectorPharmaceutical industry

Websitecosmohealthconfidence.com

All values in EUR	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	26.23M	26.23M	25.12M	25.12M
Cost of goods sold	14.02M	14.02M	13.95M	13.95M
Cost of revenue	14.02M	14.02M	13.95M	13.95M
Research and development expenses	8.09M	8.09M	7.57M	7.57M
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	6.27M	6.27M	8.32M	8.32M
Operating expense	14.97M	14.97M	15.62M	15.62M
Total operating expenses	28.99M	28.99M	29.57M	29.57M
Operating income	-2.76M	-2.76M	-4.45M	-4.45M
Other non operating income	-13.00K	-13.00K	-54.50K	-54.50K
EBT including unusual items	-124.00K	-124.00K	-1.89M	-1.89M
EBT excluding unusual items	-916.00K	-916.00K	-2.64M	-2.64M
Income tax expense	606.00K	606.00K	471.50K	471.50K
Effective tax rate	-488.71%	-488.71%	-24.89%	-24.89%
Other operating expenses	611.00K	611.00K	-265.00K	-265.00K
Net income	-801.00K	-801.00K	-2.38M	-2.38M
Net profit margin	-3.05%	-3.05%	-9.46%	-9.46%
Earnings per share	-	-	-	-
Interest and investment income	2.02M	2.02M	1.44M	1.44M
Interest expense	-28.50K	-28.50K	-56.00K	-56.00K
Net interest expenses	1.99M	1.99M	1.38M	1.38M
Depreciation and amortization charges	-	-	-	-
EBITDA	104.50K	104.50K	-1.15M	-1.15M
Gain or loss from assets sale	13.00K	13.00K	-	-

AI content may include mistakes. Learn more

HelpSend feedbackPrivacy Terms Disclaimer

Finance

Research